MP-20.16: Safety and tolerability of dutasteride, tamsulosin and a combination of dutasteride and tamsulosin: Two-year results from the Combination of Avodart ® and Tamsulosin (CombAT) study

Abstract

The ongoing CombAT study is investigating whether combination therapy with dutasteride and tamsulosin is more effective than either monotherapy alone for improvement of symptoms and long-term clinical outcomes of AUR and BPH-related prostatic surgery in a population of men aged ≥50 years with moderate-to-severe BPH symptoms and prostatic enlargement. Results of pre-planned 2-year interim safety and tolerability analyses are reported.